Desvenlafaxine in the treatment of major depressive disorder.
about
Optimizing the Use of Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: From Clinical Trials to Clinical PracticeDesvenlafaxine for the treatment of major depressive disorder.Acute and chronic effects of desvenlafaxine on gastrointestinal transit and motility in dogs.Medications for alcohol use disorders: An overview.Pharmacokinetic profiles contribute to the differences in behavioral pharmacology of 071031B enantiomers as novel serotonin and norepinephrine reuptake inhibitors.
P2860
Desvenlafaxine in the treatment of major depressive disorder.
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Desvenlafaxine in the treatment of major depressive disorder.
@ast
Desvenlafaxine in the treatment of major depressive disorder.
@en
Desvenlafaxine in the treatment of major depressive disorder.
@nl
type
label
Desvenlafaxine in the treatment of major depressive disorder.
@ast
Desvenlafaxine in the treatment of major depressive disorder.
@en
Desvenlafaxine in the treatment of major depressive disorder.
@nl
prefLabel
Desvenlafaxine in the treatment of major depressive disorder.
@ast
Desvenlafaxine in the treatment of major depressive disorder.
@en
Desvenlafaxine in the treatment of major depressive disorder.
@nl
P2860
P1476
Desvenlafaxine in the treatment of major depressive disorder.
@en
P2093
Chi-Un Pae
P2860
P304
P356
10.1517/14656566.2011.636033
P407
P577
2011-12-01T00:00:00Z